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Activation of B-cells is initiated by the ligation of B-cell receptors by its cognate antigen, inducing a series of signal cascades. 
Understanding the molecular mechanisms of these important events is a crucial goal for immunologists. Chimeric B cell re-
ceptors provide a powerful tool for analysis of B-cell signal function. However, this method can only be used in tool cells, but 
cannot be used for in vivo study. Here, we constructed a retroviral vector to encode both heavy chains and light chains of a 
membrane immunoglobulin, and expressed them in primary B-cells using retroviral gene transfer. Our results demonstrate that 
the membrane immunoglobulin expressed by retroviral vectors transfer can initiate B-cell receptor-mediated signaling, result-
ing in the phosphorylation of Syk and Erk1/2 proteins. The results showed that B-cells expressing membrane immunoglobulin 
can make proliferative responses to cognate antigen both in vitro and in vivo. Therefore, we provide a methodology for rapidly 
analyzing the downstream signals of B-cell receptors both in vitro and in vivo, which could expedite the identification of pro-
teins involved in B-cell function. 
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Various signals act via the B-cell receptor (BCR) to induce 
B-cell activation, clonal expansion, differentiation, apopto-
sis, and regulate B-cell-related immune responses (Niiro 
and Clark, 2002). Activation of B-cells is initiated by the 
ligation of the BCR by its cognate antigen, and this opens 
the gate for a series of signal cascades (Kurosaki, 2011; 
Reth and Wienands, 1997), finally resulting in the produc-
tion of antibodies against pathogenic invaders. Understand-
ing the detailed molecular mechanisms of these important 
events is a crucial goal for immunologists.  
Chimeric receptors composed of immunoglobulins (Igs) 
and individual signaling components provide a powerful 
tool for analysis of B-cell signal function. However, this 
method can only be used in tool cells such as A20 cells or in 
the myeloma cell line J558Lµm (Flaswinkel and Reth, 
1994; Sanchez et al, 1993). A20 is a BALB/c lymphoma, 
which has been used extensively for in vitro studies of anti-
gen processing (Glimcher et al, 1982). J558Lµm cells do 
not carry the cluster of differentiation 45 (CD45) surface 
marker and do not undergo any calcium response (Justemen 
et al, 1991). Therefore, these cells can only be used in vitro 
for the study of BCR-mediated signaling and cannot be used 
for in vivo study. Although the use of in vitro systems has 
provided valuable information, some complications such as 
activation and expansion are best analyzed in vivo after 
cognate antigen activation. Additionally, only one or two 
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antigen-specific BCRs are typically studied because no 
convenient methods exist to analyze the complex chain of 
events downstream of BCR. There is a need to develop new 
methodology that can facilitate the study of BCR-related 
events both in vitro and in vivo. 
BCRs located on mature B-cells contain membrane im-
munoglobulin (mIg)—an antigen-binding subunit that con-
sists of two heavy chains (IgH) and two light chains (IgL) 
of immunoglobulin—and a signaling subunit, which is a 
disulfide-linked heterodimer of the Ig- (CD79a) and Ig- 
(CD79b) proteins. In the BCR complex, mIg alone deter-
mines antigen specificity. Therefore, if we construct a vec-
tor harboring the cDNA of both IgHs and IgLs, the mIg 
expressed by the vector may interact with the transmem-
brane domains of the Ig-/Ig- (CD79) heterodimer. 
In this study, we constructed a retroviral vector contain-
ing the cDNA of both the IgHs and IgLs of a mIg and ex-
pressed this mIg in spleen B-cells using retroviral gene 
transfer. We found that the mIg expressed by a retroviral 
vector gene transfer can make proliferative responses to 
cognate antigen both in vitro and in vivo. Our study pro-
vides a method to analyze the function of antigen-specific 
BCRs both in vitro and in vivo. 
RESULTS 
Construction of retroviral vector carrying mIg- ex-
pressing cassettes 
Multiple internal promoters can be included in a retroviral 
vector. It is possible to express at least three different 
cDNAs, each from its own promoter (Overell et al, 1988). 
Based on this knowledge, we chose two promoters to con-
trol the expression of IgH and IgL. Before retroviral vector 
construction, we used a reporter assay to detect the activity 
of several promoters (Figure 1). According to the luciferase 
assay results, we chose the PGK and CMV promoters for 
the flowing retroviral vector construction based on two con-
siderations. On the one hand, packaging efficacy inversely 
correlates with the length of the retroviral construct, which 
limits the titers that can be achieved with this approach. 
Although the hEF1a and m-actin promoters scored strong-
est in the luciferase assay, they were too long to be suitable 
for retroviral vector packaging. On the other hand, the high 
activity of internal promoters may hinder 5′-LTR-driven 
EGFP expression (details in discussion). Compared with 
hEF1a and m-actin promoters, relative shorter length and 
modest activity of the PGK and CMV promoters make them 
better choices for the following retroviral vector construc-
tion. 
We carried out the retroviral vector construction as fol-
lows. First, we cloned the EGFP gene into a mouse stem 
cell virus (MSCV)-based retroviral vector to facilitate the 
identification of marked cells. The expression of the EGFP  
 
Figure 1  Activity of eight promoters analyzed by reporter assay. Activity 
of eight promoters was detected using dual-luciferase reporter assay in 
NIH3T3 cell line. The m-actin, hEF1, CMV, PGK, mEF4, LTR, hUBC 
and mEF1 promoters were cloned into pGL3-basic vectors and sequenced 
to assure fidelity. NIH3T3 cell line was transfected with these eight vectors. 
Luciferase activity was assayed 48 h after transfection using the Promega 
Luciferase Assay System according to the manufacturer’s instructions. 
Luciferase activity was normalized against transfection efficiency by using 
a pRL-CMV reporter vector (Promega) as an internal control. Results were 
expressed as the ratio of firefly luciferase to renilla luciferase activity. 
Error bars represent standard deviations as calculated from triplicates. 
m-actin, mouse -actin; hEF1, human elongation factor 1; mEF4, 
mouse elongation factor 4; LTR, long terminal repeat; hUBC, human ubiq-
uitin C; mEF1, mouse elongation factor 1. 
gene is controlled by a 5′LTR promoter (Figure 2A). Sec- 
ond, IgG 1 heavy chain (IgH) and light chain (IgL) expres- 
sion cassette elements were cloned into the retroviral vector 
mentioned above (Figure 2B). Expressions of IgH and IgL 
were controlled by the CMV and PGK promoters, respec-
tively. According to the manufacturer’s instructions of the 
retroviral vector, the transcribed mRNAs share the poly-A 
site in 3′LTR. All the cDNAs of EGFP, IgH and IgL harbor 
a termination code for their own translation termination. 
The resulting vector encodes not only the detection marker 
of EGFP but also the mIg. 
Both mIg and EGFP encoded by retroviral vector can be 
simultaneously expressed in primary B-cells 
In theory, mIg can be expressed by retroviral vector pMEIg,  
and specifically bind the cognate antigen. To validate those 
assumptions, primary B-cells were infected with retroviral 
vector pMEIg and, after 48 h, stained with labeled cognate 
antigen then analyzed by a fluorescence microscope. As 
expected, the expression of EGFP can be detected in pMEIg 
transfectant (green, Figure 3A). Expression of mIg can also 
be detected by labeled cognate antigen in the same cell (red, 
Figure 3A). To validate further the simultaneous expression 
of EGFP with mIg, primary B-cells infected with a retrovi-
ral vector expressing mIg (pMEIg) were analyzed by flow 
cytometry. Retroviral vector pMSCV-neo which expresses 
neither EGFP nor mIg was used as a negative control. In-
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fection efficiency was estimated by flow cytometric evalua-
tion of the percentage of EGFP-expressing B cells. Infection  
efficiency by retroviral vector pMEIg and pMEGFP were 
9.5% (9.5%±0.6%, n=6) and 11.4% (11.4%±0.8%, n=6) 
respectively (Figure 3B). We also found that approximately 
40% of EGFP-expressing B-cells express mIg when infect-
ed by retroviral vector pMEIg (Figure 3B). No expression 
of mIg was detected in primary B-cells infected with the 
control retroviral vector (pMSCV-neo), which also lacked 
EGFP expression (Figure 3B). No expression of mIg was 
detected in primary B-cells infected with the control retro-
viral vectors (pMSCV-neo and pMEGFP), which lacked 
mIg expression (Figure 3B). These results show that both 
mIg and EGFP encoded by retroviral vector pMEIg can be 
simultaneously expressed in primary B-cells. 
Cognate antigen binding can cause phosphorylation of 
Syk and Erk1/2 proteins 
In addition to the antigen-binding mIg, BCR contains Ig 
alpha (Ig-) and Ig beta (Ig-). In our design, a retroviral 
vector expressing mIg was associated with the disulfide- 
linked heterodimer Ig-/Ig-, which are the IgG1 subunits 
responsible for signal transduction. In order to examine the      
 
 
Figure 2  Structure of retroviral vectors pMEGFP and pMEIg. Expression of the EGFP gene is controlled by the 5′LTR promoter. Expressions of IgH and 
IgL are controlled by the CMV and PGK promoters, respectively. Arrows represent transcription initiation sites for each of the three promoters. The tran-
scribed mRNAs share the poly-A site in 3′LTR. 5′LTR, 5′ long terminal repeat; +, extended packaging signal; EGFP, enhanced green fluorescent protein 
gene; PKG P, murine phosphoglycerate kinase promoter; H-chain, the cDNA of heavy chain; CMV P, Human cytomegalovirus immediate early promoter; 
L-chain, the cDNA of light chain; 3′LTR, 3′ long terminal repeat (harboring poly-A site); Cross stars represent translation termination sites.  
 
Figure 3  Both mIg and EGFP encoded by retroviral vector can be simultaneously expressed in primary B-cell. A, Primary mouse splenocytes were infect-
ed with mIg-expressing-retroviral vector pMEIg and 48 h later stained by labeled cognate antigen (red) and the nuclei were stained with Hoechst33258 
(blue), cells were photographed under a fluorescence microscope. Images were taken at 60× magnification. The scale bar represents 20 µm in length. B, 
Primary mouse splenocytes were infected with pMSCV-neo (indicated as Mock) and mIg-expressing-retroviral vector (indicated as pMEIg) or 
non-mIg-expressing-retroviral vector (indicated as pMEGFP) and 48 h later the expression of mIg and EGFP were detected by flow cytometry. Percentage 
of mIg and EGFP are indicated. All histograms are gated on B220+ cells (left, box gates). Representative data of three experiments are shown. 
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initiation of BCR-mediated signaling, primary B-cells in-
fected by the retroviral vector were stimulated by cognate 
antigen or were left unstimulated. The phosphorylation lev-
els of Erk1/2 and Syk were analyzed by BD Phosflow. In-
fected primary B-cells were gated on B220+EGFP+ for flow 
cytometry analysis (Figure 4A). In the B-cells infected by 
mIg-expressing retroviral vector pMEIg (Figure 4B, left), 
Erk1/2 phosphorylation level is increased after cognate an-
tigen stimulation (green line) compared with the unstimu-
lated state (red line). To further exclude the possibility that 
non-specific increases in Erk1/2 phosphorylation levels 
could have been triggered by the antigens themselves, B- 
cells were also infected by a non-mIg-expressing control 
vector (pMEGFP). The results showed no significant increase 
in phosphorylation level of Erk1/2 after antigen stimulation 
(Figure 4B, middle). This result excludes the non-specific 
effect of the antigen. Similar results were also obtained for 
the Syk phosphorylation level (Figure 4C, right and middle). 
These results show that mIg expressed by retroviral vectors 
can initiate BCR-mediated signaling transduction. 
B-cells harboring vector-expressed mIg generate prolif-
erative responses to cognate antigen in vitro 
After validating that mIg expressed by retroviral vectors can 
initiate BCR-mediated signaling transduction, we wanted to 
know that whether the B-cells harboring vector-expressed 
mIg could make proliferative responses to cognate antigen. 
We first used the murine primary cells to confirm that the 
cells can get well proliferated. The results showed that ap-
proximately 20% murine primary cells can be proliferated 
with the stimulation of LPS (Figure 5A). This result 
demonstrates that the murine primary cells can be used in 
this assay. Then we tested the proliferative response by EdU 
staining in the presence of CD40L, which generated “signal 
two” of the “two-signal theory” of lymphocyte recognition 
and activation. After infection with mIg-expressing vector 
pMEIg, the cells were either treated with cognate antigen or 
PBS or left untreated as a control. Because only a small 
proportion of B-cells were infected by the retroviral vector, 
EGFP was used as a marker of the infected B-cells for 
evaluation of the proliferation of B-cells that express mIg  
 
 
Figure 4  Cognate antigen binding can cause phosphorylation of Syk and Erk1/2 proteins. A, Retroviral vector infected primary mouse B-cells were gated 
on B220+EGFP+ for further intracellular phosphospecific flow cytometry analysis. B, The phosphorylation of Erk1/2 protein of primary-B-cells infected with 
mIg-expressing-retroviral vector pMEIg (left) and non-mIg-expressing-retroviral vector pMEGFP (middle) were detected by flow cytometry. Overlay histo-
gram represents pre-incubated with cognate antigen (green line) and without cognate antigen (red line). PMA-treated cells were used as a positive control of 
Erk1/2 protein phosphorylation (right). C, The phosphorylation of Syk protein of primary-B-cells infected with mIg-expressing-retroviral vector pMEIg (left) 
and non-mIg-expressing-retroviral vector pMEGFP (middle) were detected by flow cytometry. Overlay histogram represents pre-incubated with cognate 
antigen (green line) and without cognate antigen (red line). H2O2-treated cells were used as a positive control of Syk protein phosphorylation (right). Results 
are representative of three independent experiments. 
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(Figure 5B). The proliferation rate (EdU+EGFP+cells/ 
(EdU+EGFP+cells+EdU–EGFP+cells)) was used to evaluate 
the proliferation induced by cognate antigen. The results 
show that the antigen+CD40L group had a relatively higher 
proliferation rate compared with both the CD40L group and 
control group (Figure 5B, upper, *, P<0.05). To further ex-
clude the possibility of a non-specific increase by antigen, 
B-cells were also infected by a non-mIg-expressing vector. 
Results indicated no increase in proliferation in the antigen+ 
CD40L group compared with both the CD40L group and 
the control group (Figure 5B, lower, P>0.05). These results 
demonstrate the B-cells harboring vector-expressed mIg can 
make proliferative responses to cognate antigen. 
We have previously proved that both mIg and EGFP en-
coded by a retroviral vector can be expressed simultane-
ously in a primary B-cell, we wanted to know whether 
EGFP alone could be used as a marker for the detection of 
proliferative response. We measured the proliferative re-
sponse without EdU staining (Figure 6A). The results show 
that the antigen+CD40L group mounted a relatively higher 
frequency of EGFP-positive cells compared to the CD40L 
group and control group (Figure 6B, left, **, P<0.005). To 
exclude further the possibility that non-specific increase 
expression levels could have been triggered by the antigen 
itself, B-cells were also infected by a non-mIg-expressing 
vector. As expected, no increase in EGFP-positive cells in 
the antigen+CD40L group was observed relative to the 
CD40L group and control group (Figure 6B, right, P>0.05). 
These data demonstrate that B-cells harboring a mIg-   
expressing vector can make proliferative responses to cog-
nate antigen. These results are in agreement with the EdU 




Figure 5  B-cells harboring vector-expressed mIg generate proliferative responses to cognate antigen in vitro. A, The proliferative response was detected by 
EdU staining using the murine primary cells with the stimulation of LPS. Results are representative of three independent experiments. B, The proliferative 
response was detected by EdU staining at the presence of CD40 ligand. After infection with mIg-expressing vector pMEIg, primary B-cells were treated with 
cognate antigen and CD40 Ligand, or treated with CD40 Ligand only, or left untreated indicated as control. Because a little of B-cells were infected by the 
mIg-expressing retroviral vector, EGFP was used as a marker of the infected B-cells for accurate evaluation the proliferation of mIg expressing B-cells. Data 
shown are representative of three independent experiments. The proliferation rate (EdU+EGFP+cells/(EdU+EGFP+cells+EdU-EGFP+cells)) was used to eval-
uate the proliferation induced by antigen. Results are representative of three independent experiments. The statistical significance is determined by one-way 
ANOVA. P-value is indicated (*, P<0.05). 
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the detecting marker for the proliferation assay.  
B-cells harboring vector-expressed mIg made prolifera-
tive responses to cognate antigen in vivo 
Signal transduction mediated by vector-expressed mIg was 
tested further in vivo. Splenocytes infected with retroviral 
vector pMEIg, which encode both EGFP and mIg genes, 
were adoptively transferred into SCID mouse recipients. 
Splenocytes infected with retroviral vector pMEGFP, which 
encodes only EGFP were used as a negative control. The 
recipients were then divided into two groups. One group 
was challenged with cognate antigen on day one after cell 
transfer. As a control, the other group was treated with PBS. 
After adoptive transfer, the splenocytes of recipients were 
separated and the frequency of EGFP-positive B-cells was 
detected by flow cytometry on day 18 and day 28 (Figure 
7A). Results show that the frequency of EGFP positive 
B-cells in the antigen-challenged group is significantly 
higher than that in the PBS-treated group on day 18 (Figure 
7B, ***, P<0.001). Similar results were observed on day 28. 
There is no difference of proliferation between the antigen   
 
 
Figure 6  EGFP alone can be used as a marker for the detection of proliferative response. A, Retroviral vector pMEIg infected B-cells expressing EGFP 
and antigen-specific mIg were cultured for 48 h in the presence of antigen and CD40L, or in the presence of CD40L only, or left untreated indicated as none. 
Flow cytometry detected the frequency of EGFP positive cells. Retroviral vector pMEIg infected B-cells was used as a negative control. Data shown are 
representative of three independent experiments. B, The increased frequency of EGFP positive cells was used to evaluate the proliferation induced by antigen. 
The statistical significance is determined by one-way ANOVA. P-value is indicated (**, P<0.005). 
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challenged group and un-challenged group when using con-
trol vector pMEGFP on day 18 and day 28 (Figure 7C and 
D, P>0.05). 
DISCUSSION 
In this study, we demonstrate that the membrane immuno-
globulin expressed by retroviral vectors can initiate B-cell 
receptor-mediated signaling, inducing the downstream sig-
nals of B-cell receptors. To our knowledge, this is the first 
report revealing that B-cells harboring vector-expressed mIg 
make proliferative responses to cognate antigen both in 
vitro and in vivo. 
This approach has two key advantages. First, our ap-
proach is substantially faster than transgenic technology, 
with retroviral vector construction and B-cell infection 
ready to analyze after 3 weeks. Second, although we exam-
ined only one BCR construct in this study, it is possible in 
theory that multiple BCRs can be examined simultaneously. 
This methodology is suitable for the study of analyzing the 
downstream signals and some processes of B-cell receptor, 
such as signal cascades, activation and expansion both in 
vitro and in vivo. However, we suggest that this methodol-
ogy is not suitable for some studies, such as somatic hy-
permutation (SHM) and class switch recombination (CSR)  
 
 
Figure 7  B-cells harboring vector-expressed mIg made proliferative responses to cognate antigen in vivo. A, Splenocytes (3×107) infected by a 
mIg-expressing retroviral vector pMEIg were transferred intravenously into SCID Beige mice. The recipients were then divided into two groups (n=4). One 
group was challenged with cognate antigen. As a control, the other group was treated with PBS (n=4). Flow cytometry analysis was performed to determine 
the frequency of B220+EGFP+ cells in Antigen-treated group (indicated as Ag) and PBS-treated (indicated as PBS) group on day 18 and 28. B, The frequen-
cy of EGFP positive B-cells was used to evaluate the proliferation induced by antigen. The statistical significance is determined by two-way ANOVA. 
P-value is indicated (***, P<0.001). C, Splenocytes (3×107) infected by a retroviral vector pMEGFP were transferred intravenously into SCID Beige mice. 
Flow cytometry analysis was performed to determine the frequency of B220+EGFP+ cells in Antigen-treated group (indicated as Ag) and PBS-treated group 
(indicated as PBS) on day 18 and 28. D, The frequency of EGFP positive B-cells was used to evaluate the proliferation induced by antigen. The statistical 
significance is determined by two-way ANOVA. P-value is indicated (P>0.05). 
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studies. The switch region is not contained in our mIg-  
expressing vector. Switch regions are a target for SHM, and 
sustain as high a frequency of mutation as the V region. 
Knockout mice with a partial deletion of Sµ tandem repeats 
have revealed that the deletion decreased CSR (Luby et al, 
2001; Schrader et al, 2007). When the entire 4.6 kb region 
containing Sµ tandem repeat sequences was deleted, both 
SHM and CSR were ablated (Khamlichi et al, 2004). 
Therefore, CSR, SHM and affinity maturation will not take 
place in our mIg-expressing vector. Based on the considera-
tions mentioned above, our methodology can be used to 
analyze the process of activation and expansion of B-cells, 
but may not be well-suited for the study of SHM and CSR. 
We chose dual open reading frame version based on two 
promoters for the expression of mIg, instead of a single 
open reading frame version based on 2A sequence, which 
are widely used for expression multi-gene in a single vector. 
Our approach avoids the effect of the 2A tag, which remains 
attached to the N-terminal cistron (Szymczak et al, 2004; 
Szymczak-Workman et al, 2012). This may affect signal 
processing or contribute to the antigenicity of the mIg ex-
pressed by the retroviral vector. However, the use of inter-
nal promoter elements may results in a small numbers of 
EGFP-expressing B cells simultaneously expressing intro-
duced membrane IgG1 (Figure 3B). Because the internal 
promoters and the LTR-driven expression share the same 
transcription site (Poly A) at the 3′-end of retroviral vector 
pMEIg (Figure 2B), the LTR driven transcription may be 
influenced by the internal promoters. The other reason is the 
lower driven-activity of LTR promoter compared with the 
internal promoters (Figure 1, LTR vs. CMV and PGK). The 
use of internal promoters may also reduce the titer of our ret-
roviral vector because retroviral RNA is also transcribed by 
the LTR promoter. Based on these considerations, the use of 
internal promoter with lower activity may result in less inter-
ference with LTR-driven transcription and thus increase ex-
pression of EGFP. The other method to increase the EGFP 
expression cells is to increase the transfection efficiency by 
transduction of cells at 32°C and centrifugation during 
transduction (Bunnell et al, 1995; Movassagh et al, 2000). 
Although the constructs we described can be used to an-
alyze some B-cell processes, we propose that additional 
research is required to affirm the B-cell development in 
vivo, such as B-cell positive and negative selections in the 
germinal center.  
In summary, membrane immunoglobulin expressed by 
retroviral vector gene transfer can mimic partial function of 
the B-cell receptor. Our system will allow investigators to 
assess the contribution of target molecules to B-cell signal 
transduction.  
MATERIALS AND METHODS 
Luciferase assay of promoter activity  
To construct the reporter assay vectors, all DNA promoters  
were amplified by PCR from commercialized vectors or 
human genome DNA, then subcloned into pGL3-Basic 
vector (Promega, USA). The sequences of promoters are 
available in Supplemental Materials. NIH3T3 cell line 
(ATCC, USA) was transfected with the resulting vectors. 
Luciferase activity was assayed 48 h after transfection using 
a Dual-Luciferase® Reporter Assay System according to the 
manufacturer’s instructions (Promega). Luciferase activity 
was normalized against transfection efficiency by using a 
pRL-CMV (cytomegalovirus) reporter vector (Promega) as 
an internal control. Results were expressed as the ratio of 
firefly luciferase to renilla luciferase activity. 
Construction and packaging of mIg-expressing retrovi-
ral vector 
The EGFP (enhanced green fluorescent protein) gene was 
amplified by PCR from pEGFP-C1 (Clontech, USA) and 
subcloned into the EcoR I and Bgl II sites of retroviral vec-
tor pMSCV-neo (Clontech), and the resulting vector was 
named pMEGFP. The mIg cDNA, of IgG1 isotype, was 
kindly donated by Professor Liang Mifang (Institute for 
Viral Disease Control and Prevention, Chinese Center for 
Disease Control and Prevention). This mIg is specific for 
the antigen of hantaan virus core protein. The mIg cDNA 
was subcloned into the Bgl II and Hind III sites of the 
pMEGFP vector to substitute the phosphoglycerate kinase 
(PGK) promoter and the Neo resistance cassette. The re-
sulting vector, named pMEIg, contains an EGFP gene and 
the mIg-expressing cassette. 
18 h before transfection, Platinum-E cell lines were plat-
ed onto 10 cm plates at a density of 6×106 cells per plate in 
7 mL Dulbecco’s modified eagle medium (DMEM). Trans-
fection of retroviral constructs onto Platinum-E cells was 
performed using Lipofectamine 2000 (Invitrogen, USA) 
according to the manufacturer’s instructions. 24 h after 
transfection, DMED medium was replaced with 5 mL 
RPMI (Roswell Park Memorial Institute) 1640 medium 
(Invitrogen). Viral supernatants were collected 48 h after 
transfection and filtered (0.45 µm) before used. 
Splenocyte separation and primary B-cell infection 
Spleens were obtained from 8-week-old BALB/c mice and 
placed in RPMI 1640 medium (Invitrogen). Details of the 
preparation of single spleen cell suspension have been de-
scribed in a former report (Ru and Peijie, 2009). Lympho-
cytes were cultured in RPMI1640 medium supplemented 
with 10% fetal bovine serum with 1 mmol L1 sodium py-
ruvate, 50 mol L1 beta-mercaptoethanol, nonessential 
amino acid (NEAA), and 2 mmol L1 Glutamine, and were 
stimulated with lipopolysaccharide (LPS, 50 µg mL1, Sig-
ma-Aldrich, USA) 16 h before infection. 
Retroviral vectors can only infect activated cells. Studies 
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of the activation of murine lymphocytes by mitogens have 
shown that bacterial LPS activated B-cells but not T- 
cells (Andersson et al, 1972; Blomgren et al, 1971; Greaves 
et al, 1972). Gene transfer into primary B-cells was per-
formed by cultivating splenocytes with viral supernatants in 
the presence of LPS (50 µg mL1) and polybrene  
(6 µg mL1). LPS-stimulated splenocytes (5.0×107) were 
plated in 10 mL of viral supernatants in 10 cm tissue culture 
plates, to which LPS (50 µg mL1) and polybrene (6 µg 
mL1) were also added to the culture medium. Infected 
B-cells were harvested 24 h later. 
Immunofluorescence detection 
Primary B-cells infected with retroviral vectors were tri-
ple-washed with ice-cold phosphate-buffered saline (PBS). 
Cells were then fixed with 4% paraformaldehyde solution 
for 20 min at room temperature. The cells were then washed 
with cold PBS and incubated with 0.5% Triton X-100 for 10 
min at room temperature. 3% bovine albumin (BSA) (Sig-
ma, USA) blocking solution was used followed by three 
more washes. HiLyte Fluor™ 555-conjugated (Dojindo, 
Japan) cognate antigen (hantaan virus core protein, kindly 
provided by Professor Liang Mifang, 1 µg µL1) was incu-
bated in the dark for 1 h at room temperature. The nuclei 
were then stained with Hoechst33258 after three washes 
with cold PBS. After several washes with cold PBS, cells 
were fixed to the glass surface with ProLong® Gold Anti-
fade Reagent overnight and examined by a fluorescence 
microscope (TCS-SP2, Leica, Japan). 
Intracellular phosphospecific flow cytometry 
Phosflow-specific flow cytometry assay (BD Biosciences, 
USA) was used for intracellular phosphoprotein staining in 
B-cells. After infection with various retroviral vectors, 
splenocytes were rehydrated by 5 mL PBS. Cells were re-
suspended by vortexing and centrifugation. The cell pellet 
was then washed with 1 mL PBS with 1% BSA (Sigma), 
resuspended in 50 µL PBS with 1% BSA, then split into 
new, individual flow cytometry tubes. Cognate antigen  
(5 µg) was used for activation. PBS was used as a negative 
control. Cells were fixed with prewarmed Phosflow Cytofix 
solution (BD Biosciences) at 37°C for 10 min then permea-
bilized by adding Perm Buffer III (BD Biosciences) on ice 
for 30 min. Cells were then resuspended in staining buffer 
(BD Biosciences) for intracellular phosphoprotein staining. 
Alexa Fluor 647-conjuagted anti-mouse phospho-ERK1/2 
(T202/Y204), anti-mouse ZAP-70 (Y319)/Syk (Y352) or 
mouse IgG1 isotypic antibody was added to different tubes 
and incubated at 4°C for 30 min in the dark. Cells were then 
washed twice with 10 volumes of staining buffer and pel-
leted. Samples were resuspended in 200 µL staining buffer 
and analyzed on a FACS Calibur II cytometer (BD Biosci-
ences). 
Flow cytometry to detect the expression of EGFP and 
mIg in B-cells 
Purified rat anti-mouse CD16/CD32 and PE rat anti-mouse 
CD45R/B220 were purchased from BD Biosciences. APC 
conjugation with antigen of hantaan virus core protein was 
performed using a Lightning-link Allophycocyanin-XL 
conjugation kit according to the manufacturer’s protocols. 
Single cell suspensions of splenocytes infected by retroviral 
vector were prepared. For detection, up to 106 cells were 
stained in 100 µL PBS plus 1% newborn calf serum after 
blocking with purified anti-CD16/32 mAb. B-cells were 
tracked by congenic marker PE anti-mouse CD45R/B220. 
BCRs were detected with hantaan virus core protein conju-
gated to allophycocyanin. Antibody or antigen incubations 
were for 30 min at 4°C followed by wishing once in a flow 
buffer (PBS+1% newborn calf serum). Three-color flow 
cytometry was performed using FACS Calibur flow cytom-
eter (BD Biosciences). The data were analyzed using 
CellQuest software. 
Detecting proliferative responses in vitro and in vivo 
Splenocytes infected by retroviral vector were cultured in 
RPMI1640 containing 10% fetal bovine serum (FBS), 1 
mmol L1 sodium pyruvate, 50 mol L1 beta-mercap- 
toethanol, 2 mmol L1 glutamine, and NEAA, and plated 
into 24-well plates at a concentration of 1×105 mL1 well1 
in the presence or absence of stimulators. CD40 ligand 
(CD40L, 100 ng mL1, PerProtech, USA) and cognate anti-
gen (15 µg) were used for activation. CD40L (100 ng mL1) 
and PBS were used as negative controls. After 48 h stimula-
tion, 10 µmol L1 5-ethynyl- 2′-deoxyuridine (EdU) was 
added to the medium for 3 h. The proliferating cells were 
then measured using Click-iT EdU Alexa Fluor 647 Flow 
Cytometry Assay Kits (Invitrogen) according to the manu-
facturer’s instructions. Splenocytes (3×107) infected by a 
mIg-expressing retroviral vector were transferred intrave-
nously into SCID (severe combined immune deficiency) 
Beige (Vital River Laboratories, Beijing) mice. Retroviral 
vector pMEGFP, which encodes only EGFP were used as a 
negative control. After 24 h, the mice were immunized in-
traperitoneally with 50 µg cognate antigen or with PBS. 
After adoptive transfer, the splenocytes of recipients were 
separated and the frequency of EGFP-positive cells was 
detected by flow cytometry on day 18 or day 28. 
Statistical analysis 
Data analysis was performed by using GraphPad Prism Sta-
tistical Software Version 5.0. Error bars indicate SDs. Dif-
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ferences among groups were determined with one-way or 
two-way analysis of variance (ANOVA). A value of P<0.05 
was considered as significant. 
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